Articles > Business magazines > Investing, Sales, and Marketing magazines > Research Money articles > December 1999

Article: Lorus nets $6 million after purchase warrants exercised

Article from:
Research Money
Article date:
December 22, 1999
Author:
Copyright

Lorus Therapeutics Inc has obtained nearly S6 million in equity financing through an early exercise of two series of outstanding common share purchase warrants, adding to $10 million it recently raised with a private placement of special wan-ants. The Toronto-based developer of ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Lorus Therapeutics Completes Acquisition Of GeneSense ...
Business Wire;  November 1, 1999 ;     700+ words ... ... cancer company Lorus Therapeutics Inc. ("Lorus") today announced that it has completed its acquisition of GeneSense Technologies Inc. ("GeneSense"). The merger with GeneSense will create one of the leading cancer biopharmaceutical ...

Article: Lorus Therapeutics Signs Agreement to Acquire GeneSense ...
Business Wire;  April 14, 1999 ;     700+ words ... ... it has entered into a Letter of Intent to merge with GeneSense Technologies Inc. ("GeneSense") to create one of the leading ... of other oncology-based products or companies." GeneSense Technologies Inc. is a private biopharmaceutical company that specializes ...

Article: Lorus Therapeutics Receives Shareholder Approval for the ...
Business Wire;  July 16, 1999 ;     700+ words ... ... shareholder approval to proceed with the acquisition of GeneSense Technologies Inc. ("GeneSense") and the related Special Warrant ... control over the future direction of this company." GeneSense Technologies Inc. is a private biopharmaceutical company that specializes ...

Article: Lorus Receives Fairness Opinion For GeneSense ...
Business Wire;  July 13, 1999 ;     700+ words ... ... today announced that it has received an amended fairness opinion relating to its proposed acquisition of GeneSense Technologies Inc. ("GeneSense"). The original fairness opinion was delivered by Dundee Securities Corporation ...

Article: Lorus Therapeutics Reports Second Quarter Results.
Business Wire;  January 28, 2000 ;     700+ words ... ... completed its acquisition of GeneSense Technologies Inc. For the second quarter ... of 7.21 million common share purchase warrants, issued as part of the acquisition of GeneSense Technologies Inc. (&uot;GeneSense ...

Article: [2] Lorus Therapeutics Completes Early Exercise Of Warrants For ...
Business Wire;  December 16, 1999 ;     700+ words ... ... series of outstanding common share purchase warrants. These new funds are in addition ... of 7.21 million common share purchase warrants, issued as part of the recent acquisition of GeneSense Technologies Inc., have exercised their ...

Article: Lorus Therapeutics Completes Early Exercise Of Warrants For ...
Business Wire;  December 16, 1999 ;     700+ words ... ... series of outstanding common share purchase warrants. These new funds are in addition ... of 7.21 million common share purchase warrants, issued as part of the recent acquisition of GeneSense Technologies Inc., have exercised their ...

Article: POWER PLUS Reduces Purchase Price and Extends Expiry Date of ...
PR Newswire;  April 24, 1997 ;     700+ words ... ... Class "A" and Class "B" share purchase warrants, which were to expire on April 30 ... the 2,238,281 Class "A" share purchase warrants shall now entitle holders to purchase ... purchase warrant. The Class "A" share purchase warrants will now expire June 30, 1997 as ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives